“…The synthesis of functionalized 1,2,3,4-tetrahydroquinolines (py-THQ) has attracted more and more attention due to their immense utility as biologically active building blocks and key intermediates in the manufacture of pharmaceuticals, alkaloids, agrochemicals, and other fine chemicals [1]. For example, well-known prescription and potential drugs, such as oxamniquine, nicainoprol, viratmycin, and diclofensine, all contain py-THQ units [2,3]. Currently, conventional synthesis methods used to prepare py-THQ derivatives involve catalytic cyclization [4,5], Beckman rearrangement [6], and chemoselective hydrogenation of N-heterocycles (Scheme 1(a)).…”